BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9 AND Prognosis
11 results:

  • 1. Multidisciplinary management of adolescents and young adults (AYA) sarcoma: A successful effort of an adult high-volume cancer center.
    Bertuzzi AF; Grimaudo MS; Laffi A; Giordano L; Gennaro N; Cariboni U; Siracusano LV; Quagliuolo V; Colombo P; Federico D; Renne SL; Specchia C; Cananzi F; Marrari A; Navarria P; Daolio PA; Bastoni S; Santoro A
    Cancer Med; 2023 Aug; 12(15):16254-16263. PubMed ID: 37366268
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population.
    Liu D; Liu X
    Medicine (Baltimore); 2018 Dec; 97(49):e13358. PubMed ID: 30544402
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Genetic variability of genes involved in DNA repair influence treatment outcome in osteosarcoma.
    Wang MJ; Zhu Y; Guo XJ; Tian ZZ
    Genet Mol Res; 2015 Sep; 14(3):11652-7. PubMed ID: 26436406
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Letter regarding Li JS et al. entitled "ERCC polymorphisms and prognosis of patients with osteosarcoma".
    Jian Y; Tian X; Li B; Zhou Z; Wu X
    Tumour Biol; 2015 May; 36(5):3195-6. PubMed ID: 25824708
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ERCC polymorphisms and prognosis of patients with osteosarcoma.
    Li J; Liu S; Wang W; Zhang K; Liu Z; Zhang C; Chen S; Wu S
    Tumour Biol; 2014 Oct; 35(10):10129-36. PubMed ID: 25023406
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Common gene variants in RAD51, XRCC2 and xpd are not associated with clinical outcome in soft-tissue sarcoma patients.
    Szkandera J; Absenger G; Liegl-Atzwanger B; Pichler M; Stotz M; Gerger S; Zacherl M; Renner W; Haijun M; Leithner A; Gerger A
    Cancer Epidemiol; 2013 Dec; 37(6):1003-9. PubMed ID: 24189466
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors.
    Yang LM; Li XH; Bao CF
    Asian Pac J Cancer Prev; 2012; 13(11):5883-6. PubMed ID: 23317281
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of four ERCC1 and ercc2 SNPs with survival of bone tumour patients.
    Hao T; Feng W; Zhang J; Sun YJ; Wang G
    Asian Pac J Cancer Prev; 2012; 13(8):3821-4. PubMed ID: 23098477
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy.
    Biason P; Hattinger CM; Innocenti F; Talamini R; Alberghini M; Scotlandi K; Zanusso C; Serra M; Toffoli G
    Pharmacogenomics J; 2012 Dec; 12(6):476-83. PubMed ID: 21826087
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathologic study of 24 patients with primary cardiac sarcomas: a 10-year single institution experience.
    Kim CH; Dancer JY; Coffey D; Zhai QJ; Reardon M; Ayala AG; Ro JY
    Hum Pathol; 2008 Jun; 39(6):933-8. PubMed ID: 18538171
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Expressions of ercc2 and ERCC4 genes in osteosarcoma and peripheral blood lymphocytes and their clinical significance].
    Li X; Guo W; Shen DH; Yang RL; Liu J; Zhao H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 39(5):467-71. PubMed ID: 17940561
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.